ArticleInternational journal of general medicine2025
Development and Validation of a Nomogram for Predicting Hyperuricemia in Perimenopausal Women.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and validate a nomogram model for predicting the risk of hyperuricemia (HUA) in perimenopausal women. Methods: In this study, physical examination information of perimenopausal women was collected at the First Affiliated Hospital of University of Science and Technology of China. We utilized the Least Absolute Shrinkage and Selection Operator (Lasso) and binary logistic regression to investigate the risk factors of HUA among perimenopausal women. Results: We finally collected 5637 patients in this study. Based on the results of Lasso-logistic regression analysis, we incorporated ten different independent variables into the risk prediction model for HUA. The risk prediction model showed good discrimination ability in both the training set (AUC=0.819; 95% CI=0.801~0.838) and validation set (AUC=0.787; 95% CI=0.756~0.818), the calibration curve demonstrates that the model was well-calibrated. In addition, we constructed HUA risk prediction models for perimenopausal women with BMI < 25.0 and BMI ≥ 25.0, respectively. The AUC of the prediction model in the population with BMI < 25.0 was 0.793, and the AUC of the prediction model in the population with BMI ≥ 25.0 was 0.765. Conclusion: Our study identified several independent risk factors for HUA in perimenopausal women and developed a prediction mode, which might be used to detect the individual conditions and implement the preventive interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.